Article
Paricalcitol reduces peritoneal fibrosis in mice through the activation of regulatory T cells and reduction in IL-17 production.
PloS one - 1 Jan 2014
González-Mateo Guadalupe T, Fernández-Míllara Vanessa, Bellón Teresa, Liappas Georgios, Ruiz-Ortega Marta, López-Cabrera Manuel, Selgas Rafael, Aroeira Luiz S
Abstract excerpt
Fibrosis is a significant health problem associated with a chronic inflammatory reaction. The precise mechanisms involved in the fibrotic process are still poorly understood. However, given that inflammation is a major causative factor, immunomodulation is a possible therapeutic approach to reduce fibrosis. The vitamin D receptor (VDR) that is present in all hematopoietic cells has been associated with...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
